argenx SE | ARGX - Operating Expenses

Stock Price
714.60
Daily Change
1.00 0.14%
Monthly
4.53%
Yearly
13.18%
Q1 Forecast
686.63

argenx SE reported $776.99M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
AstraZeneca USD 16.69B 5.74B Sep/2025
Galapagos EUR 112.83M 9.48M Sep/2025
Genmab DKK 565M 38M Jun/2025
GlaxoSmithKline GBP 5.76B 203M Sep/2025
GRIFOLS EUR 1.51B 28.3M Sep/2025
Hikma Pharmaceutical USD 642M 663M Jun/2025
Qiagen NV USD 395.29M 2.28M Sep/2025
UCB EUR 2.36B 108M Dec/2024